Joyce Colussi-Mas
Overview
Explore the profile of Joyce Colussi-Mas including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
167
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Truman P, Atigari D, Kidwell M, Colussi-Mas J, Ellenbroek B
Psychopharmacology (Berl)
. 2024 Nov;
242(3):617-628.
PMID: 39556208
Rationale: Tobacco monoamine oxidase (MAO) inhibitors have long been suspected of influencing tobacco dependence, but direct evidence of their effects has been difficult to obtain. Recently we have identified two...
2.
Bradbury S, Bird J, Colussi-Mas J, Mueller M, Ricaurte G, Schenk S
Addict Biol
. 2013 Jun;
19(5):874-84.
PMID: 23763615
The current study aimed to elucidate the role of pharmacokinetic (PK) parameters and neurotransmitter efflux in explaining variability in (±) 3, 4-methylenedioxymethamphetamine (MDMA) self-administration in rats. PK profiles of MDMA...
3.
Schenk S, Abraham B, Aronsen D, Colussi-Mas J, Do J
Psychopharmacology (Berl)
. 2013 Jan;
227(2):355-61.
PMID: 23354536
A consistent effect of repeated exposure to 3,4 methylenedioxymethamphetamine (MDMA) is a decrease in the tissue levels of serotonin (5-HT). A variety of behavioural and neurochemical tests were conducted to...
4.
Jones K, Brennan K, Colussi-Mas J, Schenk S
Addict Biol
. 2010 May;
15(3):289-98.
PMID: 20477756
Tolerance to the behavioural effects of 3,4-methylenedioxymethamphetamine (MDMA) following high dose exposure has been attributed to alterations in serotonergic systems. The present study aimed to determine whether decreased 5-HT release...
5.
Colussi-Mas J, Wise R, Howard A, Schenk S
Int J Neuropsychopharmacol
. 2010 Mar;
13(10):1315-27.
PMID: 20334725
In laboratory animals, exposure to priming injections of 3,4-methylenedioxymethamphetamine (MDMA) produced drug seeking following extinction of MDMA self-administration. This study aimed to evaluate whether the magnitude of drug seeking was...
6.
Brennan K, Colussi-Mas J, Carati C, Lea R, Fitzmaurice P, Schenk S
Brain Res
. 2009 Dec;
1317:137-46.
PMID: 19962371
A number of studies have shown that exposure to high doses of methamphetamine (MA) is toxic to central dopamine (DA) and serotonin (5-HT) neurons. In most of those studies, however,...
7.
Colussi-Mas J, Schenk S
Eur J Neurosci
. 2008 Nov;
28(9):1895-910.
PMID: 18973603
The behavioral profile in response to (+/-)-3,4-methylenedioxymethamphetamine (MDMA) is characterized by acute hyperlocomotion that is primarily restricted to the periphery of the open field, whereas behavioral sensitization to MDMA reflects...
8.
Brennan K, Lake B, Hely L, Jones K, Gittings D, Colussi-Mas J, et al.
Behav Pharmacol
. 2007 Nov;
18(8):785-90.
PMID: 17989516
The ability of benzylpiperazine (BZP) to substitute for cocaine and to initiate self-administration in drug-naive subjects was assessed to determine whether BZP has abuse liability. Further, the effects of a...
9.
Colussi-Mas J, Geisler S, Zimmer L, Zahm D, Berod A
Eur J Neurosci
. 2007 Aug;
26(4):1011-25.
PMID: 17714194
The ventral tegmental area (VTA), primary source of the mesocorticolimbic dopaminergic system, is regarded as a critical site for initiation of behavioural sensitization to psychostimulants. The present study was undertaken...
10.
Colussi-Mas J, Panayi F, Scarna H, Renaud B, Berod A, Lambas-Senas L
Int J Neuropsychopharmacol
. 2005 Apr;
8(4):569-81.
PMID: 15836801
Recent findings have given evidence a role for noradrenergic transmission in the mechanisms underlying behavioural sensitization to psychostimulants. This work was undertaken to investigate the possible role of beta-adrenergic receptors...